Global and China Small Molecule Active Pharmaceutical Ingredient Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Small Molecule Active Pharmaceutical Ingredient industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Johnson & Johnson

    • Teva Pharmaceuticals

    • GlaxoSmithKline

    • Siegfried Holding AG

    • Johnson Matthey

    • Boehringer Ingelheim GmbH

    • Bristol-Myers Squibb

    • BASF SE

    • Cambrex Corporation

    • Roche

    • PCAS

    • AstraZeneca

    • Pfizer

    • Bachem Holding AG

    • Novartis AG,

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Standard API

    • High Potency API

    Application:

    • Cardiovascular Diseases

    • Respiratory Disorders

    • Infectious Diseases

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Small Molecule Active Pharmaceutical Ingredient Industry Overview

      • 1.1.1 Small Molecule Active Pharmaceutical Ingredient Market Scope and Market Segments

      • 1.1.2 Small Molecule Active Pharmaceutical Ingredient Industry Characteristics

      • 1.1.3 Global and China Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Small Molecule Active Pharmaceutical Ingredient Production Value and Growth Rate (2017-2028)

    • 1.2 Global Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Standard API

      • 1.2.2 High Potency API

    • 1.3 Global Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Cardiovascular Diseases

      • 1.3.2 Respiratory Disorders

      • 1.3.3 Infectious Diseases

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Small Molecule Active Pharmaceutical Ingredient Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Small Molecule Active Pharmaceutical Ingredient Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Small Molecule Active Pharmaceutical Ingredient Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Small Molecule Active Pharmaceutical Ingredient Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Small Molecule Active Pharmaceutical Ingredient Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Small Molecule Active Pharmaceutical Ingredient Industry Porter's Five Forces Model Analysis

      • 2.2.3 Small Molecule Active Pharmaceutical Ingredient Industry PEST Analysis

    • 2.3 Small Molecule Active Pharmaceutical Ingredient Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Small Molecule Active Pharmaceutical Ingredient Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Small Molecule Active Pharmaceutical Ingredient Industry

    Chapter 3 Global and China Small Molecule Active Pharmaceutical Ingredient Market, by Manufacturer

    • 3.1 Global and China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Small Molecule Active Pharmaceutical Ingredient Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Small Molecule Active Pharmaceutical Ingredient Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Small Molecule Active Pharmaceutical Ingredient Market Top 3 Players

    Chapter 4 Global and China Small Molecule Active Pharmaceutical Ingredient Market, by Type (2017-2028)

    • 4.1 Small Molecule Active Pharmaceutical Ingredient Market Trend, by Type

    • 4.2 Global Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Small Molecule Active Pharmaceutical Ingredient Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Small Molecule Active Pharmaceutical Ingredient Price Trend, by Type (2017-2028)

    • 4.3 China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Small Molecule Active Pharmaceutical Ingredient Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Small Molecule Active Pharmaceutical Ingredient Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Small Molecule Active Pharmaceutical Ingredient Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Small Molecule Active Pharmaceutical Ingredient Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Small Molecule Active Pharmaceutical Ingredient Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Small Molecule Active Pharmaceutical Ingredient Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Small Molecule Active Pharmaceutical Ingredient Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Small Molecule Active Pharmaceutical Ingredient Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Small Molecule Active Pharmaceutical Ingredient Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Small Molecule Active Pharmaceutical Ingredient Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Small Molecule Active Pharmaceutical Ingredient Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Small Molecule Active Pharmaceutical Ingredient Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Small Molecule Active Pharmaceutical Ingredient Market Analysis

    • 7.1 North America Small Molecule Active Pharmaceutical Ingredient Market, by Type

    • 7.2 North America Small Molecule Active Pharmaceutical Ingredient Market, by Application

    • 7.3 North America Small Molecule Active Pharmaceutical Ingredient Market Analysis and Forecast, by Country

      • 7.3.1 United States Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Small Molecule Active Pharmaceutical Ingredient Market Analysis

    • 8.1 Europe Small Molecule Active Pharmaceutical Ingredient Market, by Type

    • 8.2 Europe Small Molecule Active Pharmaceutical Ingredient Market, by Application

    • 8.3 Europe Small Molecule Active Pharmaceutical Ingredient Market Analysis and Forecast, by Country

      • 8.3.1 Germany Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Small Molecule Active Pharmaceutical Ingredient Market Analysis

    • 9.1 APAC Small Molecule Active Pharmaceutical Ingredient Market, by Type

    • 9.2 APAC Small Molecule Active Pharmaceutical Ingredient Market, by Application

    • 9.3 APAC Small Molecule Active Pharmaceutical Ingredient Market Analysis and Forecast, by Country

      • 9.3.1 China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Analysis

    • 10.1 Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market, by Type

    • 10.2 Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market, by Application

    • 10.3 Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Small Molecule Active Pharmaceutical Ingredient Company Profiles

      • 11.1 Johnson & Johnson

        • 11.1.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.1.3 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Teva Pharmaceuticals

        • 11.2.1 Teva Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.2.3 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 GlaxoSmithKline

        • 11.3.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.3.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Siegfried Holding AG

        • 11.4.1 Siegfried Holding AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.4.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Johnson Matthey

        • 11.5.1 Johnson Matthey Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.5.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Boehringer Ingelheim GmbH

        • 11.6.1 Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.6.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Bristol-Myers Squibb

        • 11.7.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.7.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 BASF SE

        • 11.8.1 BASF SE Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 BASF SE Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.8.3 BASF SE Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Cambrex Corporation

        • 11.9.1 Cambrex Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.9.3 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Roche

        • 11.10.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Roche Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.10.3 Roche Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 PCAS

        • 11.11.1 PCAS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 PCAS Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.11.3 PCAS Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 AstraZeneca

        • 11.12.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.12.3 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Pfizer

        • 11.13.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Pfizer Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.13.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Bachem Holding AG

        • 11.14.1 Bachem Holding AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.14.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Novartis AG,

        • 11.15.1 Novartis AG, Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Product Profiles, Application and Specification

        • 11.15.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Small Molecule Active Pharmaceutical Ingredient Industry Investment Prospect and Risk Assessment

    • 12.1 Small Molecule Active Pharmaceutical Ingredient Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Small Molecule Active Pharmaceutical Ingredient Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Production Value and Growth Rate (2017-2028)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Production Value and Growth Rate (2017-2028)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Standard API (2017-2028)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of High Potency API (2017-2028)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Cardiovascular Diseases (2017-2028)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Respiratory Disorders (2017-2028)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Infectious Diseases (2017-2028)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Small Molecule Active Pharmaceutical Ingredient Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Small Molecule Active Pharmaceutical Ingredient Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Small Molecule Active Pharmaceutical Ingredient Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Small Molecule Active Pharmaceutical Ingredient Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Small Molecule Active Pharmaceutical Ingredient Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Small Molecule Active Pharmaceutical Ingredient Market Share, by Manufacturer in 2021

    • Figure Global and China Small Molecule Active Pharmaceutical Ingredient Market Share, by Manufacturer in 2022

    • Table Global Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Type (2017-2028)

    • Table Global Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Type (2017-2028)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Type (2017-2028)

    • Table Global Small Molecule Active Pharmaceutical Ingredient Sales Value, by Type (2017-2028)

    • Table Global Small Molecule Active Pharmaceutical Ingredient Sales Value Share, by Type (2017-2028)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Price Trend, by Type (2017-2028)

    • Table China Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Type (2017-2028)

    • Table China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Type (2017-2028)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Type (2017-2028)

    • Table China Small Molecule Active Pharmaceutical Ingredient Sales Value, by Type (2017-2028)

    • Table China Small Molecule Active Pharmaceutical Ingredient Sales Value Share, by Type (2017-2028)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Price Trend, by Type (2017-2028)

    • Table Global Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Application (2017-2028)

    • Table Global Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Application (2017-2028)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Application (2017-2028)

    • Table Global Small Molecule Active Pharmaceutical Ingredient Sales Value, by Application (2017-2028)

    • Table Global Small Molecule Active Pharmaceutical Ingredient Sales Value Share, by Application (2017-2028)

    • Figure Global Small Molecule Active Pharmaceutical Ingredient Sales Value Share, by Application (2017-2028)

    • Table China Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Application (2017-2028)

    • Table China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Application (2017-2028)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Application (2017-2028)

    • Table China Small Molecule Active Pharmaceutical Ingredient Sales Value, by Application (2017-2028)

    • Table China Small Molecule Active Pharmaceutical Ingredient Sales Value Share, by Application (2017-2028)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Value Share, by Application (2017-2028)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Production, Import, Consumption and Export (2017-2022)

    • Figure North America Small Molecule Active Pharmaceutical Ingredient Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Small Molecule Active Pharmaceutical Ingredient Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Small Molecule Active Pharmaceutical Ingredient Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Production, Import, Consumption and Export (2017-2022)

    • Table North America Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Type (2017-2028)

    • Table North America Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Type (2017-2028)

    • Figure North America Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Type (2017-2028)

    • Table North America Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Application (2017-2028)

    • Table North America Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Application (2017-2028)

    • Figure North America Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Application (2017-2028)

    • Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure United States Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Canada Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Table Europe Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Type (2017-2028)

    • Table Europe Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Type (2017-2028)

    • Figure Europe Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Type (2017-2028)

    • Table Europe Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Application (2017-2028)

    • Table Europe Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Application (2017-2028)

    • Figure Europe Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Application (2017-2028)

    • Figure Germany Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure UK Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure UK Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure France Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure France Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Italy Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Spain Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Poland Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Russia Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Table APAC Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Type (2017-2028)

    • Table APAC Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Type (2017-2028)

    • Figure APAC Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Type (2017-2028)

    • Table APAC Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Application (2017-2028)

    • Table APAC Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Application (2017-2028)

    • Figure APAC Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Application (2017-2028)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Japan Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure India Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure India Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Small Molecule Active Pharmaceutical Ingredient Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Small Molecule Active Pharmaceutical Ingredient Sales Value and Growth Rate (2017-2028)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceuticals Product Profiles, Application and Specification

    • Table Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Siegfried Holding AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Siegfried Holding AG Product Profiles, Application and Specification

    • Table Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson Matthey Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson Matthey Product Profiles, Application and Specification

    • Table Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim GmbH Product Profiles, Application and Specification

    • Table Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BASF SE Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BASF SE Product Profiles, Application and Specification

    • Table BASF SE Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cambrex Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cambrex Corporation Product Profiles, Application and Specification

    • Table Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table PCAS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table PCAS Product Profiles, Application and Specification

    • Table PCAS Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bachem Holding AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bachem Holding AG Product Profiles, Application and Specification

    • Table Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG, Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG, Product Profiles, Application and Specification

    • Table Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.